CCTA is the Future of Coronary Risk Stratification
Georgia Heart Institute
57 videos
Georgia Heart Institute is Georgia’s forward-thinking Heart and Vascular program and is home to the life changing innovators who continually find new ways to improve health for generations.
The...
Georgia Heart Institute is Georgia’s forward-thinking Heart and Vascular program and is home to the life changing innovators who continually find new ways to improve health for generations.
The Future of Heart Care, We’re Leading Georgia There.
nghs.com/heart/for-clinicians
Speakers
Dr. Mehta is a nuclear, general and preventive cardiologist at the NHBLI Intramural Research Program. He is also...
Dr. Mehta is a nuclear, general and preventive cardiologist at the NHBLI Intramural Research Program. He is also Professor of Medicine at the George Washington University where he attends on the coronary care unit. His research program focuses on the role of innate immunity and inflammation in subclinical atherosclerosis. He utilizes psoriasis as a human model to study cardiometabolic diseases. His trans-disciplinary approach involves genetic epidemiology, cardiovascular radiology and translational medicine to perform observational and experimental studies in humans. Dr. Mehta’s group has shown that severity of inflammation in skin relates to lipoprotein dysfunction, insulin resistance, lipid-rich coronary plaque by CCTA and vascular inflammation by FDG PET/CT. His group recently demonstrated that lipid-rich coronary plaque decreased following successful skin disease treatment with biologic therapy. Dr. Mehta has expertise in leading large collaborative teams. His background in lipidology, Preventive Cardiology,Nuclear Cardiology and Epidemiology facilitate multi-disciplinary science.
Start a conversation